ARTICLE | Company News

LoneStar Heart, University of Texas Southwestern Medical Center deal

January 30, 2012 8:00 AM UTC

LoneStar received exclusive, worldwide rights from the university to develop and commercialize Isoxazoles for diabetes. The small molecules can increase or restore insulin production in dormant or dysfunctional pancreatic cells, and are in discovery for the indication. LoneStar said the compounds also have the potential to differentiate progenitor cells in the heart to become cardiac muscle cells. ...